Nerli R B, Pujar V C, Hiremath M B, Jali S M, Joshi S S, Hiremath S C, Guntaka A K
KLES Kidney Foundation, KLES Dr Prabhakar Kore Hospital & MRC, Belgaum, Karnataka India ; Department of Urology, KLE University's JN Medical College, Belgaum, 590010 India.
KLES Kidney Foundation, KLES Dr Prabhakar Kore Hospital & MRC, Belgaum, Karnataka India.
Indian J Surg Oncol. 2014 Mar;5(1):11-6. doi: 10.1007/s13193-013-0284-1. Epub 2014 Jan 22.
The initial therapy for most children with Wilms tumor is radical nephrectomy. Several centers, have explored the role of Nephron-sparing procedures in children with unilateral non-syndromic Wilms tumors. The primary motivation for this approach is concern about late occurrence of renal dysfunction after unilateral nephrectomy. We report our experience with NSS for unilateral non-syndromic Wilms tumor. We reviewed the records of nine children who underwent nephron sparing surgery for unilateral, nonsyndromic Wilms tumors at our Hospital between Jan 2000 through Jan 2012. All patients received preoperative chemotherapy with two drugs (vincristine, and dactinomycin) following which patients underwent tumor resection. Subsequent renal function was assessed by estimating the glomerular filtration rate using creatinine clearance and other measures of long-term renal function assessment included blood pressure evaluation and the need for antihypertensive medications. During the study period nine children with a mean age 19.66 ± 14.37 months at diagnosis and presenting with unilateral non-syndromic Wilms tumor underwent nephron sparing surgery. In all the nine children, the renal plane of resection showed a tumor-free margin. Post-operative serum creatinine repeated at the end of 3 months revealed maintenance of good renal function in all children. Nephron sparing surgery is a safe and effective option in the management of early stage unilateral non-syndromic Wilms tumor. It is oncologically safe and does not lead to decreased local tumor control. The function of the kidney remnant remains rather well.
大多数肾母细胞瘤患儿的初始治疗方法是根治性肾切除术。有几个中心探讨了保留肾单位手术在单侧非综合征性肾母细胞瘤患儿中的作用。采用这种方法的主要动机是担心单侧肾切除术后肾功能不全的晚期发生。我们报告了我们对单侧非综合征性肾母细胞瘤进行保留肾单位手术(NSS)的经验。我们回顾了2000年1月至2012年1月期间在我院接受单侧非综合征性肾母细胞瘤保留肾单位手术的9名儿童的记录。所有患者术前接受了两种药物(长春新碱和放线菌素)的化疗,随后进行了肿瘤切除。通过使用肌酐清除率估计肾小球滤过率来评估后续肾功能,其他长期肾功能评估措施包括血压评估和使用抗高血压药物的必要性。在研究期间,9名诊断时平均年龄为19.66±14.37个月且患有单侧非综合征性肾母细胞瘤的儿童接受了保留肾单位手术。在所有9名儿童中,肾脏切除平面显示无肿瘤边缘。术后3个月末复查的血清肌酐显示所有儿童的肾功能均保持良好。保留肾单位手术是早期单侧非综合征性肾母细胞瘤治疗中的一种安全有效的选择。它在肿瘤学上是安全的,不会导致局部肿瘤控制率下降。残余肾脏的功能保持相当良好。